Pharmafile Logo
Pharmafocus logo
Advanced Search
bayer_cross_2

FDA approves first new drug for liver cancer in decade

April 28, 2017
Medical Communications, Sales and Marketing Bayer, Stivarga, hepatocellular carcinoma, liver cancer

The FDA has announced that it has approved the first new treatment for hepatocellular carcinoma (HCC), a type of liver …

News
733px-reduction_gear

The five competencies of continuous regulatory compliance

April 28, 2017
Medical Communications pharmafile, regulatory compliance

Look at any country or region with a strong generic pharmaceutical and active ingredient manufacturing sector, and you are sure …

News
thorkil_kastberg_christensen_provided_photo

SAB Biotherapeutics moves to bolster board

April 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

SAB Biotherapeutics, a clinical-stage biopharmaceutical development company, announced that it had appointed Thorkil Kastberg Christensen to its Board of Directors. …

Appointment
blood-75302_960_720

Blood test able to detect cancer a year in advance

April 27, 2017
Research and Development Cancer Research UK, Francis Crick Institute, cancer research

A team at the Francis Crick Institute, based in London, has discovered a new way of analysing blood in patients …

News
depression

Mental health spending to sink by £4.5 million

April 27, 2017
Medical Communications NHS, mental health

Here at Pharmafocus, we highlighted the state of mental health research and the alternative paths that are being trod to …

News
head-196541_960_720

Mental health: Time for a new kind of therapy?

April 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing mental health

It’s no secret that mental health is not taken as seriously as its physical counterpart. It has been an uphill …

Feature
pregnancy

Cheap drug could prevent thousands of maternal deaths worldwide

April 27, 2017
Research and Development postpartum haemorrhage

A drug that has been available to patients for many years may have found a new use to prevent mothers …

News
eyal-desheh

Teva has another high profile role to fill

April 27, 2017
Sales and Marketing Eyal Desheh, Teva, Teva Pharmaceuticals

Teva’s gaps at the top level of its structure continue to build, as Eyal Desheh is set to leave his …

News

ABPI calls for a “world-class NHS” with 2017 General Election Manifesto

April 27, 2017
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Theresa May, general election

With Theresa May’s announcement of a snap election in earlier this month, the life sciences industry erupted into fiery discourse. …

News
astrazeneca_building_white

AZ’s Tagrisso continues successes with EU approval

April 26, 2017
Research and Development, Sales and Marketing AstraZeneca, EU, European Commission, NSCLC, Tagrisso

More good news for AstraZeneca’s Tagrisso (osimertinib), as the company announces that the European Commission has granted the drug full …

News

FDA condemns 14 companies selling fraudulent cancer ‘cures’ online

April 26, 2017
Research and Development, Sales and Marketing Cancer, FDA

The FDA has struck out against a wave of companies offering cancer treatments online which fraudulently claim to be able …

News
shutterstock_95714119

Research identifies marker for aggressive ovarian cancer

April 26, 2017
Research and Development Cancer, ovarian cancer

Scientists have identified a marker which they believe can inform whether a tumour will become more aggressive and pose a …

News
shutterstock_92671375

Sanofi launches lawsuit against Mylan over “illegal business practices”

April 26, 2017
Research and Development, Sales and Marketing Auvi-Q, Mylan, Sanofi, epipen, lawsuit

In a move that is sure to pile even more pressure onto Mylan after the company’s recent woes, Sanofi has …

News
pharmafocus_may_cover

The May 2017 issue of Pharmafocus is now live!

April 26, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus

The latest edition of Pharmafocus is available to read now! In this issue we delve into pharma’s reaction to the …

News

Rasna Therapeutics appoints new CEO

April 25, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Rasna Therapeutics, the UK-based biotech that specialises in developing treatments for leukaemia, has announced the appointment of a new CEO. …

Appointment
uk_location_in_the_eu_2016

Pharma industry calls for EMA relocation by June in open EFPIA letter

April 25, 2017
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA

Heads of research from 19 of the biggest players in the industry have called for a decision to be made …

News
stent

Indian government goes to war over 75% stent price reduction

April 25, 2017
Manufacturing and Production India, cardiac stents

The National Pharmaceutical Pricing Authority (NPPA), India’s drug pricing regulator, moved to lower the price of the newest generation of …

News

EMA gives positive opinion on Biogen’s spinal muscular atrophy drug Spinraza

April 25, 2017
Manufacturing and Production, Sales and Marketing Biogen, Ionis, Spinraza, spinal muscular atrophy

Biogen has revealed that Spinraza (nusinersen), its treatment for spinal muscular atrophy (SMA) , has received a positive opinion from …

News
surgery

Quarter of cancer patients visit GP three times with no diagnosis

April 25, 2017
Manufacturing and Production, Research and Development Cancer, GP, NHS, oncology

A recent study, published in the British Journal of General Practice, has found that 23% of those suffering from cancer …

News
japan-112722_640

Japanese pharma expects 17% growth throughout 2017

April 25, 2017
Manufacturing and Production CPhI, Japan

Pharma companies attending CPhI Japan are expecting a 17% growth of the country’s market throughout the year, according to data …

News
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026